Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC79 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
mRNA | NRXN1 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | DYM | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | STMN1 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
mRNA | KLHL24 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | ZNF43 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-09 |
mRNA | CTXN2 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | DTNA | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
mRNA | ZNF669 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |